1
项与 Anti-CD20/CD30-CAR-T Cell(Shanghai Tongji Hospital) 相关的临床试验An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.
This study is a single-center,open-label,single-dose clinical trial of anti-CD20/CD30-CAR-T cell therapy in relapsed/refractory B-cell tumor patients after lymphocyte depletion pre-treatment.
In this study phase,a traditional "3+3"trial design is employed for dose escalation.
100 项与 Anti-CD20/CD30-CAR-T Cell(Shanghai Tongji Hospital) 相关的临床结果
100 项与 Anti-CD20/CD30-CAR-T Cell(Shanghai Tongji Hospital) 相关的转化医学
100 项与 Anti-CD20/CD30-CAR-T Cell(Shanghai Tongji Hospital) 相关的专利（医药）
100 项与 Anti-CD20/CD30-CAR-T Cell(Shanghai Tongji Hospital) 相关的药物交易
